Global Arthropod-Borne Viral Infection Testing Market Size, Trends & Growth Opportunity, By Test Type (ELIASA-Based Tests, RT-PCR Based Test, and Others), By End User (Hospitals, Diagnostic Laboratories, Research Centers, and Others), By Region, And By Forecast Till 2027.
Global Arthropod-Borne Viral Infection Testing Market
The Global Arthropod-Borne Viral Infection Testing Market is expected to grow from US$ 1.3 Billion in 2021 to US$ 1.9 Billion by 2027; it is estimated to grow at a CAGR of 6.52% from 2022 to 2027.
Market Overview
Arthropod-Borne Viral Infections are caused by a group of viruses spread to humans by the bite of insects or infected arthropods like mosquitoes. These infections are also known as arboviral infections. Arthropod-borne viral infection examples include Chikungunya, Yellow Fever, California encephalitis, and St.Louis encephalitis. This type of infection ranges in the severity of diseases from no symptoms to mild-flu-like symptoms. 
Market Drivers 
One of the significant factors anticipated to accelerate the development and demand of the market for testing for arthropod-borne viral infections is the increase in the applicability of diagnostics to other infections. Additionally, throughout the forecast period, it is anticipated that the rapid emergence of arboviruses, increased public health challenges, and integrated government initiatives will all contribute to the development of the global market. Along with rising healthcare costs, the prevalence of different arbovirus disorders is also expected to rise, which will likely accelerate market expansion. Furthermore, among the important factors anticipated to propel the development of the market for testing arthropod-borne viral infections are the high population at risk for infections and the high distribution of arboviruses. 
 Market Restraints
 The main factor anticipated to restrain the growth of the global market for testing for arthropod-borne viral infections is a dearth of in vitro facilities. Additionally, a lack of knowledge about diagnostic testing methods and their limited availability will hinder market expansion.
Impact of Covid-19 on Arthropod-Borne Viral Infection Testing
Pharmaceutical and biotech companies are working with governments all over the globe to combat the COVID-19 outbreak, from vaccine research to overcoming supply chain challenges. There are approximately 115 vaccine candidates and an additional 155 compounds in the R&D process. Additionally, the demand for COVID-19 treatment has greatly increased due to commonly used drugs like hydroxychloroquine. Additionally, there is an increased need for COVID-19 management medications, which is expected to create a sizable chance for pharmaceutical companies since many developed nations require these drugs. Due to the rising demand for COVID-19 vaccines and treatment drugs, the pharmaceutical and biotechnology industries are anticipated to grow considerably over the coming years.
Market Segmentation
The global market for testing arthropod-borne viral infections is divided into different segments based on test type, end-user, and region. The test type segment includes ELIASA-based tests, RT-PCR-based tests, and others. The RT-PCR-based tests segment is expected to dominate the market due to its advantages and was the leading segment in 2020, likely to maintain this position during the forecast period. The end-user segment comprises hospitals, diagnostic laboratories, research centers, and others. The market is also segmented by region into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. North America is predicted to dominate the global market due to its developed economy, high healthcare spending, and widespread adoption of advanced technology.
Market Key Players
Various key players are discussed in this report such as Bio-Rad, Copley Scientific, Acmas Technologie, Fluke Biomedical, Datrend System, Achico, Agilent Technologies, Ahlborn, AESKU.GROUP, and BioMed.
Industrial Development
• Dengue fever diagnostic kits will be available in November 2021 from Achico, a Swiss-based healthcare technology firm. The company's DNA aptamer technology platform, which successfully identifies COVID-19, would serve as the foundation for this new test kit.
Market Taxonomy
By Test Type
• ELIASA-based Tests
• RT-PCR based Test
• Others
By End User
• Hospitals
• Diagnostic Laboratories
• Research Centers
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Arthropod-Borne Viral Infection Testing Market?
• What will be the growth rate from 2022 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
• What are the strategies adopted by key players?
 

Global Arthropod-Borne Viral Infection Testing Market 
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Arthropod-Borne Viral Infection Testing Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5  Global Arthropod-Borne Viral Infection Testing Market, By Test Type
5.1 Y-o-Y Growth Comparison, By Test Type 
5.2 Global Arthropod-Borne Viral Infection Testing Market Share Analysis, By Test Type 
5.3 Global Arthropod-Borne Viral Infection Testing Market Size and Forecast, By Test Type
5.3.1 ELISA –Based Test
5.3.2 RT-PCR based Test
5.3.3 Others
6  Global Arthropod-Borne Viral Infection Testing Market, By End User
6.1 Y-o-Y Growth Comparison, By End User
6.2 Global Arthropod-Borne Viral Infection Testing Market Share Analysis, By End User
6.3 Global Arthropod-Borne Viral Infection Testing Market Size and Forecast, By End User
6.3.1 Hospital
6.3.2Diagnostic Laboratories
6.3.3Research Centres
6.3.4Others
7 Global Arthropod-Borne Viral Infection Testing Market, By Region
7.1 Global Arthropod-Borne Viral Infection Testing Market Share Analysis, By Region
7.2 Global Arthropod-Borne Viral Infection Testing Market Size and Forecast, By Region
8 North America Arthropod-Borne Viral Infection Testing Market Analysis and Forecast (2022 – 2027)
8.1 Introduction
8.2 North America Arthropod-Borne Viral Infection Testing Market Share Analysis, By Test Type
8.3 North America Arthropod-Borne Viral Infection Testing Market Size and Forecast, By End User
8.4 North America Arthropod-Borne Viral Infection Testing Market Size and Forecast, By Country
8.4.1 U.S
8.4.2 Canada
8.4.3 Mexico
9 Europe Arthropod-Borne Viral Infection Testing Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 Europe Arthropod-Borne Viral Infection Testing Market Share Analysis, By Test Type 
9.3 Europe Arthropod-Borne Viral Infection Testing Market Size and Forecast, By End User 
9.4 Europe Arthropod-Borne Viral Infection Testing Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10Asia Pacific Arthropod-Borne Viral Infection Testing Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Asia Pacific Arthropod-Borne Viral Infection Testing Market Share Analysis, By Test Type 
10.3 Asia Pacific Arthropod-Borne Viral Infection Testing Market Size and Forecast, By End User 
10.4 Asia Pacific Arthropod-Borne Viral Infection Testing Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11Latin America Arthropod-Borne Viral Infection Testing Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Latin America Arthropod-Borne Viral Infection Testing Market Share Analysis, By Test Type 
11.3 Latin America Arthropod-Borne Viral Infection Testing Market Size and Forecast, By End User 
11.4 Latin America Arthropod-Borne Viral Infection Testing Market Size and Forecast, By Country
11.4.1. Brazil
11.4.2 Rest of Latin America
12Middle East Arthropod-Borne Viral Infection Testing Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Middle East Arthropod-Borne Viral Infection Testing Market Share Analysis, By Test Type 
12.3 Middle East Arthropod-Borne Viral Infection Testing Market Size and Forecast, By End User 
12.4 Middle East Arthropod-Borne Viral Infection Testing Market Size and Forecast, By Country
14.4.1 Saudi Arabia
14.4.2 UAE
14.4.3 Egypt
14.4.4 Kuwait
14.4.5 South Africa
13Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
15.1 Bio-Rad
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Copley Scientific
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Acmas Technologie
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Fluke Biomedical
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Datrend System
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Agilent Technologies
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Ahlborn
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 AESKU.GROUP
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 BioMed
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Achico
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies